Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pediatr Allergy Immunol. 2018 Feb;29(1):58-65. doi: 10.1111/pai.12811. Epub 2017 Nov 2.
Blinded food challenges are considered the current gold standard for the diagnosis of food allergies. We used data from a pan-European multicenter project to assess differences between study centers, aiming to identify the impact of subjective aspects for the interpretation of oral food challenges.
Nine study centers of the EuroPrevall birth cohort study about food allergy recruited 12 049 newborns and followed them for up to 30 months in regular intervals. Intensive training was conducted and every center visited to ensure similar handling of the protocols. Suspected food allergy was clinically evaluated by double-blind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms.
Of 839 challenges conducted, study centers confirmed food allergy in 15.6% to 53.6% of locally conducted challenges. Centers reported 0 to 16 positive placebo challenges. Worsening of eczema was the most common sign when challenged with placebo. Agreement between documented objective signs and the challenge outcome assigned by the physician was heterogeneous, with Cohen's kappa spanning from 0.42 to 0.84.
These differences suggest that the comparison of food challenge outcomes between centers is difficult despite common protocols and training. We recommend detailed symptom assessment and documentation as well as objective sign-based challenge outcome algorithms to assure accuracy and comparability of blinded food challenges. Training and supervision of staff conducting food challenges is a mandatory component of reliable outcome data.
盲法食物挑战被认为是食物过敏诊断的当前金标准。我们使用来自泛欧多中心项目的数据评估了研究中心之间的差异,旨在确定主观因素对口服食物挑战解释的影响。
关于食物过敏的 EuroPrevall 出生队列研究的 9 个研究中心招募了 12049 名新生儿,并在定期间隔长达 30 个月的时间内对其进行随访。进行了密集培训,每个中心都进行了访问,以确保协议的处理方式相似。通过使用九级剂量递增方案的双盲、安慰剂对照食物挑战来临床评估疑似食物过敏。根据医生评估的主要挑战结果与记录的体征和症状进行比较。
在进行的 839 次挑战中,研究中心在本地进行的挑战中确认食物过敏的比例为 15.6%至 53.6%。中心报告的阳性安慰剂挑战数量为 0 至 16 次。用安慰剂进行挑战时,湿疹恶化是最常见的体征。记录的客观体征与医生分配的挑战结果之间的一致性存在差异,Cohen's kappa 范围为 0.42 至 0.84。
尽管存在共同的方案和培训,但这些差异表明中心之间的食物挑战结果比较具有挑战性。我们建议详细的症状评估和记录以及基于客观体征的挑战结果算法,以确保盲法食物挑战的准确性和可比性。对进行食物挑战的工作人员进行培训和监督是可靠结果数据的强制性组成部分。